Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control Study

<i>Background and Objectives</i>: Inherited thrombophilia (IT) increases the risk of adverse pregnancy outcomes, but the benefit of low-molecular-weight heparin (LMWH) prophylaxis remains debated. This study aimed evaluate the effect of LMWH by analyzing outcomes in women with IT who rec...

Full description

Saved in:
Bibliographic Details
Main Authors: Dragana Maglic, Vesna Mandic-Markovic, Zeljko Mikovic, Rastko Maglic, Radomir Anicic, Milica Mandic
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/61/7/1131
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849408958180098048
author Dragana Maglic
Vesna Mandic-Markovic
Zeljko Mikovic
Rastko Maglic
Radomir Anicic
Milica Mandic
author_facet Dragana Maglic
Vesna Mandic-Markovic
Zeljko Mikovic
Rastko Maglic
Radomir Anicic
Milica Mandic
author_sort Dragana Maglic
collection DOAJ
description <i>Background and Objectives</i>: Inherited thrombophilia (IT) increases the risk of adverse pregnancy outcomes, but the benefit of low-molecular-weight heparin (LMWH) prophylaxis remains debated. This study aimed evaluate the effect of LMWH by analyzing outcomes in women with IT who received LMWH versus those who did not and also compare pregnancy complication rates before and after inherited thrombophilia diagnosis. <i>Materials and Methods</i>: We conducted a retrospective case–control study including 276 pregnant women with inherited thrombophilia and prior pregnancy complications and 276 healthy pregnant controls on delivery. The main outcome was the incidence of complications: preterm rupture of membranes, oligohydramnios, fetal growth restriction, preterm delivery, stillbirth, HELLP syndrome, gestational hypertension, deep vein thrombosis, and recurrent pregnancy loss. The effect of LMWH was assessed by comparing complication rates among inherited thrombophilia patients who received therapy versus those who did not. <i>Results</i>: Women with IT were older, had higher BMI, delivered earlier, and had neonates with lower birth weight compared to controls. In current pregnancies, LMWH was associated with reduced rates of preterm delivery, fetal growth restriction, gestational hypertension, and recurrent pregnancy loss, especially in factor V Leiden carriers. LMWH had little effect on low-risk genotypes and was not independently associated with outcome reduction. <i>Conclusions</i>: LMWH prophylaxis should be reserved for high-risk women with IT. Routine use in all IT pregnancies is not justified and may cause unnecessary risks and costs. Early screening, risk stratification, and individualized care are essential to optimize outcomes.
format Article
id doaj-art-ae9ddac0df6748dc94e0d132c21b2a44
institution Kabale University
issn 1010-660X
1648-9144
language English
publishDate 2025-06-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-ae9ddac0df6748dc94e0d132c21b2a442025-08-20T03:35:38ZengMDPI AGMedicina1010-660X1648-91442025-06-01617113110.3390/medicina61071131Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control StudyDragana Maglic0Vesna Mandic-Markovic1Zeljko Mikovic2Rastko Maglic3Radomir Anicic4Milica Mandic5Faculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, SerbiaFaculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, SerbiaFaculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, SerbiaFaculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, SerbiaFaculty of Medicine, University of Belgrade, Dr Subotica 8, 11000 Belgrade, SerbiaDepartment for High-Risk Pregnancies, University Clinic for Gynecology and Obstetrics “Narodni Front”, Kraljice Natalije 62, 11000 Belgrade, Serbia<i>Background and Objectives</i>: Inherited thrombophilia (IT) increases the risk of adverse pregnancy outcomes, but the benefit of low-molecular-weight heparin (LMWH) prophylaxis remains debated. This study aimed evaluate the effect of LMWH by analyzing outcomes in women with IT who received LMWH versus those who did not and also compare pregnancy complication rates before and after inherited thrombophilia diagnosis. <i>Materials and Methods</i>: We conducted a retrospective case–control study including 276 pregnant women with inherited thrombophilia and prior pregnancy complications and 276 healthy pregnant controls on delivery. The main outcome was the incidence of complications: preterm rupture of membranes, oligohydramnios, fetal growth restriction, preterm delivery, stillbirth, HELLP syndrome, gestational hypertension, deep vein thrombosis, and recurrent pregnancy loss. The effect of LMWH was assessed by comparing complication rates among inherited thrombophilia patients who received therapy versus those who did not. <i>Results</i>: Women with IT were older, had higher BMI, delivered earlier, and had neonates with lower birth weight compared to controls. In current pregnancies, LMWH was associated with reduced rates of preterm delivery, fetal growth restriction, gestational hypertension, and recurrent pregnancy loss, especially in factor V Leiden carriers. LMWH had little effect on low-risk genotypes and was not independently associated with outcome reduction. <i>Conclusions</i>: LMWH prophylaxis should be reserved for high-risk women with IT. Routine use in all IT pregnancies is not justified and may cause unnecessary risks and costs. Early screening, risk stratification, and individualized care are essential to optimize outcomes.https://www.mdpi.com/1648-9144/61/7/1131inherited thrombophiliapregnancy complicationslow-molecular-weight heparinfactor V Leidenfetal growth restriction risk stratification
spellingShingle Dragana Maglic
Vesna Mandic-Markovic
Zeljko Mikovic
Rastko Maglic
Radomir Anicic
Milica Mandic
Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control Study
Medicina
inherited thrombophilia
pregnancy complications
low-molecular-weight heparin
factor V Leiden
fetal growth restriction risk stratification
title Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control Study
title_full Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control Study
title_fullStr Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control Study
title_full_unstemmed Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control Study
title_short Impact of Inherited Thrombophilia on Pregnancy Complications and the Role of Low-Molecular-Weight Heparin Therapy: A Case–Control Study
title_sort impact of inherited thrombophilia on pregnancy complications and the role of low molecular weight heparin therapy a case control study
topic inherited thrombophilia
pregnancy complications
low-molecular-weight heparin
factor V Leiden
fetal growth restriction risk stratification
url https://www.mdpi.com/1648-9144/61/7/1131
work_keys_str_mv AT draganamaglic impactofinheritedthrombophiliaonpregnancycomplicationsandtheroleoflowmolecularweightheparintherapyacasecontrolstudy
AT vesnamandicmarkovic impactofinheritedthrombophiliaonpregnancycomplicationsandtheroleoflowmolecularweightheparintherapyacasecontrolstudy
AT zeljkomikovic impactofinheritedthrombophiliaonpregnancycomplicationsandtheroleoflowmolecularweightheparintherapyacasecontrolstudy
AT rastkomaglic impactofinheritedthrombophiliaonpregnancycomplicationsandtheroleoflowmolecularweightheparintherapyacasecontrolstudy
AT radomiranicic impactofinheritedthrombophiliaonpregnancycomplicationsandtheroleoflowmolecularweightheparintherapyacasecontrolstudy
AT milicamandic impactofinheritedthrombophiliaonpregnancycomplicationsandtheroleoflowmolecularweightheparintherapyacasecontrolstudy